logo

ICICI Pru Pharma Healthcare Diag Gr

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

ICICI Pru Pharma Healthcare Diag Gr

as of 16 Mar 2026, 13:20 PM

Scheme Asset Size₹6801.16 Cr
Expense Ratio1.86%
Cash Holding2.02004%
Fund TypeOpen-End
PlanGrowth
BenchmarkBSE Healthcare TR INR
Launch Date2018-07-12
Exit LoadExit load of 1.00% for investments if redeemed within 15 Days

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months -0.58%
In the last 3 months -6.19%
In the last 6 months -7.36%
In the last 1 Years 8.17%
In the last 3 Years 1.08%
In the last 5 Years 1.16%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE11.21%
Cipla LtdHealthcareE9.40%
Mankind Pharma LtdHealthcareE7.64%
Dr Reddy's Laboratories LtdHealthcareE6.52%
Biocon LtdHealthcareE6.20%
Divi's Laboratories LtdHealthcareE5.95%
Lupin LtdHealthcareE3.99%
Aurobindo Pharma LtdHealthcareE3.70%
Alkem Laboratories LtdHealthcareE3.47%
Syngene International LtdHealthcareE3.16%
Cohance Lifesciences LtdHealthcareE2.77%
Medplus Health Services LtdHealthcareE2.54%
Alivus Life Sciences LtdHealthcareE2.11%
Zydus Lifesciences LtdHealthcareE2.07%
Akums Drugs and Pharmaceuticals LtdHealthcareE1.77%
J.B. Chemicals & Pharmaceuticals LtdHealthcareE1.75%
Thyrocare Technologies LtdHealthcareE1.75%
Alembic Pharmaceuticals LtdHealthcareE1.60%
Gland Pharma LtdHealthcareE1.54%
Entero Healthcare Solutions LtdHealthcareE1.46%
Pfizer LtdHealthcareE1.34%
Medi Assist Healthcare Services LtdHealthcareE1.31%
Blue Jet Healthcare LtdHealthcareE1.22%
Metropolis Healthcare LtdHealthcareE1.21%
Glenmark Pharmaceuticals LtdHealthcareE1.19%
Fine Organic Industries Ltd Ordinary SharesBasic MaterialsE1.17%
Hikal LtdHealthcareE1.15%
Anthem Biosciences LtdHealthcareE1.09%
Aarti Drugs LtdHealthcareE0.98%
Shilpa Medicare LtdHealthcareE0.97%
Windlas Biotech LtdHealthcareE0.95%
Sanofi Consumer Healthcare India LtdHealthcareE0.88%
AstraZeneca Pharma India LtdHealthcareE0.76%
Senores Pharmaceuticals LtdHealthcareE0.71%
FDC LtdHealthcareE0.63%
Laxmi Dental LtdHealthcareE0.63%
Nephrocare Health Services LtdHealthcareE0.48%
Sun Pharma Advanced Research Co LtdHealthcareE0.45%
Rubicon Research LtdHealthcareE0.26%
Tbill-BT0.03%
Treps-CR2.18%
Net Current Assets-C0.19%
Cash Margin - Derivatives-CA0.00596%
Procter & Gamble Health Ltd-E-

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

97.98%

Cash

2.02%

Equity sector allocation

Loading chart…

Basic Materials

1.17%

Healthcare

96.81%

Others

2.02%

Fund House Contact Details

Websitewww.icicipruamc.com
Phone+91 22 26428000
Logo
ICICI Prudential Asset Management Co Ltd

Asset Management Company

About ICICI Pru Pharma Healthcare Diag Gr

Investment Objective of the Scheme

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

Key Features of The Fund

5-year return

+16.61%

Fund Manager

Dharmesh Kakkad

Risk Profile

Very High Risk

Expense Ratio

1.86%

Fund Size

₹6801.16 Cr

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy